During the past decade, Medizinische Hochschule Hannover - Klinik für Pneumologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medizinische Hochschule Hannover - Klinik für Pneumologie" #1 sponsor was "Actelion" with 4 trials, followed by "Hannover Medical School" with 3 trials sponsored, "CSL Behring" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Hochschule Hannover - Klinik für Pneumologie" #1 collaborator was "CAPNETZ Stiftung" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "German Center for Lung Research" with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Jena University Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Medizinische Hochschule Hannover - Klinik für Pneumologie" are "Chronic Thromboembolic Pulmonary Hypertension" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Pulmonary Arterial Hypertension" (2 trials), "ARDS" (1 trials) and "Bronchiectasis" (1 trials). Many other conditions were trialed in "Medizinische Hochschule Hannover - Klinik für Pneumologie" in a lesser frequency.

Most popular intervention types in "Medizinische Hochschule Hannover - Klinik für Pneumologie" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Macitentan" (2 trials), "Selexipag" (2 trials), "CSL312" (1 trials) and "PRM-151 (Zinpentraxin Alfa)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medizinische Hochschule Hannover - Klinik für Pneumologie" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Medizinische Hochschule Hannover - Klinik für Pneumologie". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Medizinische Hochschule Hannover - Klinik für Pneumologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Medizinische Hochschule Hannover - Klinik für Pneumologie, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".